Marsoni S, Torri V, Taiana A, Liberati A, Labianca R, Pancera G, Gray R, Clarke M

Efficacy of intraportal infusion for colon cancer: a fair assessment?

J Clin Oncol 1991; 888-9. doi: 10.1200/JCO.1991.9.5.888

Grilli R, Alexanian A, Apolone G, Fossati R, Marsoni S, Nicolucci A, Torri V, Zola P, Compagnucci M, Di Mambro E

The impact of cancer treatment guidelines on actual practice in Italian general hospitals: the case of ovarian cancer.

Ann Oncol 1990; 112-8. doi: 10.1093/oxfordjournals.annonc.a057687

Marsoni S, Torri V, Valsecchi MG, Belloni C, Bianchi U, Bolis G, Bonazzi C, Colombo N, Epis A, Favalli G

Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)).

Br J Cancer 1990; 444-50. doi: 10.1038/bjc.1990.315

Marsoni S, Ungerleider RS, Hurson SB, Simon RM, Hammershaimb LD

Tolerance to antineoplastic agents in children and adults.

Cancer Treat Rep 1985; 1263-9.

Grilli R, Alexanian AA, Apolone G, Confalonieri C, Fossati R, Liati P, Liberati MC, Marsoni S, Mosconi P, Monferroni N

Trends in patterns of care for breast cancer in Italy (1979-1987).

Tumori 1990; 184-9. doi: 10.1177/030089169007600207

Apolone G, Grilli R, Alexanian AA, Confalonieri C, Labianca R, Liati P, Marsoni S, Martignoni G, Mosconi P, Nicoluci A

Quality of care of colorectal cancer patients in general hospitals: diffusion and impact of management guidelines.

Tumori 1990; 261-9. doi: 10.1177/030089169007600311

Erba E, Ubezio P, Pepe S, Vaghi M, Marsoni S, Torri W, Mangioni C, Landoni F, D'Incalci M

Flow cytometric analysis of DNA content in human ovarian cancers.

Br J Cancer 1989; 45-50. doi: 10.1038/bjc.1989.217

Weiss RB, Grillo-López AJ, Marsoni S, Posada JG, Hess F, Ross BJ

Amsacrine-associated cardiotoxicity: an analysis of 82 cases.

J Clin Oncol 1986; 918-28. doi: 10.1200/JCO.1986.4.6.918

Marsoni S, Hoth D, Simon R, Leyland-Jones B, De Rosa M, Wittes RE

Clinical drug development: an analysis of phase II trials, 1970-1985.

Cancer Treat Rep 1987; 71-80.

Foster BJ, Clagett-Carr K, Marsoni S, Simon R, Leyland-Jones B

Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?

Cancer Treat Rep 1986; 1003-14.

Bizzi A, Codegoni AM, Landoni F, Marelli G, Marsoni S, Spina AM, Torri W, Mangioni C

Steroid receptors in epithelial ovarian carcinoma: relation to clinical parameters and survival.

Cancer Res 1988; 6222-6.

Estey E, Hoth D, Simon R, Marsoni S, Leyland-Jones B, Wittes R

Therapeutic response in phase I trials of antineoplastic agents.

Cancer Treat Rep 1986; 1105-15.

Liberati A, Mangioni C, Bratina L, Carinelli G, Marsoni S, Parazzini F, Regallo M, Talamini R, Tognoni G

Process and outcome of care for patients with ovarian cancer.

Br Med J (Clin Res Ed) 1985; 1007-12. doi: 10.1136/bmj.291.6501.1007

Wittes RE, Marsoni S, Simon R, Leyland-Jones B

The phase II trial.

Cancer Treat Rep 1985; 1235-9.

Libretti A, Piazza E, Scanni A, Tomirotti M, Biraghi M, Scapaticci R, Bianchi C, Restelli G, Scarpazza G, Calzavara MP, Marsoni S, Morasca L

Bleomycin, vincristine, and methotrexate (BOM) in squamous cell carcinoma of the lung: a phase II study.

Cancer Treat Rep 1981; 171-2.

%PLACEHOLDER%